EGFR Pathway Mutations in Lung Cancer Patient Tumors and Blood
OBJECTIVES:
- Examine the mutational status of the EGFR pathway in tumor and blood samples from
patients with lung cancer.
- Correlate the EGFR pathway mutations in these samples with clinical outcomes of these
patients.
OUTLINE: Archived tumor tissue and blood samples are analyzed via PCR to detect EGFR pathway
mutations in DNA.
Observational
N/A
Mutational status of the EGFR pathway
No
Philip C. Mack, PhD
Principal Investigator
University of California, Davis
Unspecified
CDR0000583056
NCT00899405
May 2005
Name | Location |
---|---|
University of California Davis Cancer Center | Sacramento, California 95817 |